Evidence map›Paper›PMID 42148566›Full record

ArticleJournal of diabetes science and technology2026

Evaluating the Accuracy, Quality, and Reproducibility of AI Chatbot-Generated Diabetes Self-Management Education and Support Plans Aligned With ADCES7.

Teng-Hung Yu, Hui-Chun Hsu, Yau-Jiunn Lee, Wei-Hua Tang

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Teng-Hung YuDivision of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung.
Hui-Chun HsuDepartment of Nursing, Lee's Endocrinology Clinic, Pingtung.
Yau-Jiunn LeeDepartment of Internal Medicine, Lee's Endocrinology Clinic, Pingtung.
Wei-Hua TangDivision of Cardiology, Department of Internal Medicine, Ministry of Health and Welfare Yuli Hospital, Hualien.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rapid development of artificial intelligence, particularly large language models (LLMs) such as ChatGPT, Gemini, and Claude, offers new opportunities to scale and personalize diabetes self-management education and support (DSMES). This study evaluated the quality, accuracy, and reproducibility of DSMES plans generated by ChatGPT-5 using the ADCES7 Self-Care Behaviors™ framework.

methodsEleven virtual patient profiles representing five key DSMES time points (diagnosis, annual review, complicating factors, transitions, and ongoing care) were analyzed using structured prompts with retrieval-augmented generation. Generated plans were assessed using a DSMES Process Evaluation Checklist integrating IMPACTS, QAMAI, PDQI-9, and Donabedian's frameworks across ten domains. Content validity was confirmed by five experts (S-CVI: 0.982 for appropriateness; 0.964 for clarity). Ten certified diabetes educators (mean age 47.9 years; mean experience 14 years) independently scored the plans. Internal consistency, inter-rater reliability, and reproducibility were examined.

resultsMean domain scores ranged from 29.0 ± 2.0 (patient engagement; 58.0%) to 42.7 ± 2.0 (cultural and linguistic appropriateness; 85.5%). ChatGPT-5 demonstrated strengths in clarity (85.1%) and goal-directedness (81.1%), generating evidence-based plans within three to five minutes, but showed limitations in patient engagement. Moderate performance was observed for accuracy (74.9%), relevance (78.7%), individualization (79.6%), and feasibility (75.3%). Reliability was high (Cronbach's α = 0.889; intra-class correlation coefficient = 0.837). Reproducibility was moderate, with intra-assay coefficients of 0.04 to 0.15 and inter-assay coefficients of 0.10 to 0.27.

conclusionsThe DSMES process evaluation checklist is valid and reliable. ChatGPT-5 shows promise as a scalable DSMES decision-support tool, though improvements in personalization, patient engagement, and reproducibility are needed before broader implementation.

Indexed as

AI chatbotcertified diabetes care and education specialistsdiabetes self-management education and supportreliability

Identifiers

PMID42148566
PMCPMC13183789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.